tiprankstipranks
Trending News
More News >
Gyre Therapeutics (GYRE)
NASDAQ:GYRE
US Market
Advertisement

Gyre Therapeutics (GYRE) Financial Statements

Compare
819 Followers

Gyre Therapeutics Financial Overview

Gyre Therapeutics's market cap is currently $678.48M. The company's EPS TTM is $0; its P/E ratio is 458.28; Gyre Therapeutics is scheduled to report earnings on August 11, 2025, and the estimated EPS forecast is $0.05. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Currency in USD

Gyre Therapeutics Earnings and Revenue History

Gyre Therapeutics Debt to Assets

Gyre Therapeutics Cash Flow

Gyre Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis